Leadership change at Healogics targets growth and development strategies.
- Healogics has welcomed John P. Landino as Chief Development Officer.
- Landino brings extensive healthcare experience to the role.
- The appointment aims to enhance strategies for growth and patient care.
Healogics, a leader in wound care management, has appointed John P. Landino as its new Chief Development Officer. This leadership change is part of the company's strategy to enhance its growth and development initiatives within the healthcare sector. With his extensive background in healthcare, Landino is expected to contribute significantly to Healogics' mission and operations.
Previously, Landino held various executive roles that focused on healthcare development and strategy. His expertise includes navigating complex healthcare environments and implementing effective management practices. This new appointment aims to reinforce Healogics' commitment to improving patient care while expanding its market reach.
Landino's leadership is anticipated to enhance partnerships and foster innovative solutions in wound care. His focus will be on driving strategies that align with the company's objectives, ensuring optimal patient outcomes and service delivery.
